Skip to main content

Find Clinical Trials

Home
Conditions
Claudin 18.2

Clinical trial condition

Claudin 18.2

Explore clinical trials studying Claudin 18.2. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Claudin 18.2 trial results

Not Yet Recruiting

A Phase I/II Study of FG-M108 Plus FG-B901 in Advanced CLDN18.2-Positive Solid Tumors

NCT07704866

Conditions: Claudin 18.2, Solid Tumor Malignancies
Locations: Harbin Medical University Cancer Hospital Ha’erbin, China

The First Hospital of China Medical University Shenyang, China

View Trial Details

Active, Not Recruiting

Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

NCT05994001

Conditions: Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations: Zhongshan hospital, Fudan University Shanghai, China

View Trial Details